About Xenocor
Xenocor is a company based in Salt Lake City (United States) founded in 2000.. Xenocor has raised $10 million across 3 funding rounds from investors including GenHenn Capital, Patel Family Investments and Mountain Pacific Venture Partners. Xenocor offers products and services including Saberscope and HD Image Optimizer. Xenocor operates in a competitive market with competitors including Olympus, SurgiQuest, Eximis Surgical, New View Surgical and Genicon, among others.
- Headquarter Salt Lake City, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Xenocor
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$10 M (USD)
in 3 rounds
-
Latest Funding Round
$10 M (USD), Unspecified
Mar 21, 2023
-
Investors
GenHenn Capital
& 2 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Xenocor
Xenocor offers a comprehensive portfolio of products and services, including Saberscope and HD Image Optimizer. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Provides single-use HD camera for enhanced laparoscopic visualization and safety.
Replaces traditional systems for plug-and-play surgical monitoring.
Unlock access to complete
Unlock access to complete
Funding Insights of Xenocor
Xenocor has successfully raised a total of $10M across 3 strategic funding rounds. The most recent funding activity was a Unspecified round of $10 million completed in March 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Unspecified — $10.0M
- First Round First Round
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2023 | Amount | Unspecified - Xenocor | Valuation | GenHenn Capital | |
| Jun, 2021 | Amount | Unspecified - Xenocor | Valuation |
investors |
|
| Oct, 2020 | Amount | Unspecified - Xenocor | Valuation | Mountain Pacific Venture Partners |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Xenocor
Xenocor has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include GenHenn Capital, Patel Family Investments and Mountain Pacific Venture Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Xenocor
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Xenocor
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Xenocor Comparisons
Competitors of Xenocor
Xenocor operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Olympus, SurgiQuest, Eximis Surgical, New View Surgical and Genicon, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Manufacturer of imaging and surgical products
|
|
| domain | founded_year | HQ Location |
Products for minimally invasive surgery are developed and supplied.
|
|
| domain | founded_year | HQ Location |
Minimal invasive specimen removal tools
|
|
| domain | founded_year | HQ Location |
Minimally invasive systems for laparoscopic surgery are developed.
|
|
| domain | founded_year | HQ Location |
Patented laparoscopic instruments are designed, manufactured, and distributed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Xenocor
Frequently Asked Questions about Xenocor
When was Xenocor founded?
Xenocor was founded in 2000 and raised its 1st funding round 20 years after it was founded.
Where is Xenocor located?
Xenocor is headquartered in Salt Lake City, United States. It is registered at Salt Lake City, Utah, United States.
Who is the current CEO of Xenocor?
Ashok Khandkar is the current CEO of Xenocor.
Is Xenocor a funded company?
Xenocor is a funded company, having raised a total of $10M across 3 funding rounds to date.
What does Xenocor do?
Xenocor was founded in 2000 and is headquartered in Salt Lake City, United States. Operations focus on the medical device sector, where sterile, single-use laparoscopic scopes are developed for minimally invasive surgeries. The Xenoscope device, cleared under FDA 510(k) K171344, enables high-definition real-time imaging and supports procedures in remote or power-limited environments. Multi-purpose functionality is emphasized for surgical versatility.
Who are the top competitors of Xenocor?
Xenocor's top competitors include Olympus, New View Surgical and SurgiQuest.
What products or services does Xenocor offer?
Xenocor offers Saberscope and HD Image Optimizer.
Who are Xenocor's investors?
Xenocor has 3 investors. Key investors include GenHenn Capital, Patel Family Investments, and Mountain Pacific Venture Partners.